VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease.

Mutant Huntingtin (mtHtt) causes neurodegeneration in Huntington's disease (HD) by evoking defects in the mitochondria, but the underlying mechanisms remains elusive. Our proteomic analysis identifies valosin-containing protein (VCP) as an mtHtt-binding protein on the mitochondria. Here we show that VCP is selectively translocated to the mitochondria, where it is bound ...
to mtHtt in various HD models. Mitochondria-accumulated VCP elicits excessive mitophagy, causing neuronal cell death. Blocking mtHtt/VCP mitochondrial interaction with a peptide, HV-3, abolishes VCP translocation to the mitochondria, corrects excessive mitophagy and reduces cell death in HD mouse- and patient-derived cells and HD transgenic mouse brains. Treatment with HV-3 reduces behavioural and neuropathological phenotypes of HD in both fragment- and full-length mtHtt transgenic mice. Our findings demonstrate a causal role of mtHtt-induced VCP mitochondrial accumulation in HD pathogenesis and suggest that the peptide HV-3 might be a useful tool for developing new therapeutics to treat HD.
Mesh Terms:
Adult, Animals, Apoptosis, Behavior, Animal, Cell Line, Corpus Striatum, Disease Models, Animal, Fibroblasts, Humans, Huntingtin Protein, Huntington Disease, Male, Mice, Mice, Transgenic, Mitochondria, Mitochondrial Degradation, Mutant Proteins, Neurons, Peptides, Primary Cell Culture, Protein Binding, Protein Transport, Proteomics, Rats, Valosin Containing Protein
Nat Commun
Date: Dec. 26, 2015
Download Curated Data For This Publication
213638
Switch View:
  • Interactions 12